Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · IEX Real-Time Price · USD
2.025
+0.055 (2.79%)
Jul 22, 2024, 11:36 AM EDT - Market open
Mersana Therapeutics Employees
Mersana Therapeutics had 123 employees as of December 31, 2023. The number of employees decreased by 105 or -46.05% compared to the previous year.
Employees
123
Change (1Y)
-105
Growth (1Y)
-46.05%
Revenue / Employee
$311,366
Profits / Employee
-$1,096,041
Market Cap
246.56M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
2seventy bio | 274 |
Utah Medical Products | 190 |
Cibus | 183 |
Gossamer Bio | 135 |
Semler Scientific | 92 |
Design Therapeutics | 58 |
Rezolute | 51 |
Cybin | 50 |
MRSN News
- 2 months ago - Mersana Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024 - GlobeNewsWire
- 5 months ago - Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 5 months ago - Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024 - GlobeNewsWire
- 6 months ago - Mersana Therapeutics to Participate in Guggenheim's 6th Annual Biotechnology Conference - GlobeNewsWire
- 7 months ago - Mersana Therapeutics Announces Business Updates, Expected 2024 Milestones and Upcoming Presentation at the 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire